Exploring TKIs in metastatic sarcomas: Results of REGOBONE osteosarcoma cohort
Professor Jean-Yves Blay and Professor Florence Duffaud
Exploring TKIs in metastatic sarcomas: Results of REGOBONE osteosarcoma cohort ( Professor Jean-Yves Blay and Professor Florence Duffaud )
14 Nov 2019
REGOSARC – activity of regorafenib in advanced non-adipocytic STS
Professor Jean-Yves Blay and Professor Florence Duffaud
REGOSARC – activity of regorafenib in advanced non-adipocytic STS ( Professor Jean-Yves Blay and Professor Florence Duffaud )
14 Nov 2019
Implementing national cancer control plans
Dr Eduardo Cazap and Dr Lisa Stevens
Implementing national cancer control plans ( Dr Eduardo Cazap and Dr Lisa Stevens )
24 Jun 2019
ANNOUNCE: Combination of olaratumab and doxorubicin versus doxorubicin alone in ...
Dr William Tap - Memorial Sloan Kettering Cancer Center, New York, USA
ANNOUNCE: Combination of olaratumab and doxorubicin versus doxorubicin alone in patients with advanced soft tissue sarcomas ( Dr William Tap - Memorial Sloan Kettering Cancer Center, New York, USA )
6 Jun 2019
Highlights from ASCO 2019
Asst. Prof Bishal Gyawali and Monique Biryiana
Highlights from ASCO 2019 ( Asst. Prof Bishal Gyawali and Monique Biryiana )
3 Jun 2019
HER2-targeted CAR T-cell therapy safe and showing promising antitumour activity ...
Prof Shoba Navai - Baylor College of Medicine, Houston, USA
HER2-targeted CAR T-cell therapy safe and showing promising antitumour activity in patients with advanced sarcoma ( Prof Shoba Navai - Baylor College of Medicine, Houston, USA )
11 Apr 2019
New developments in soft tissue and bone sarcoma research
Prof Hans Gelderblom - Universiteit Leiden, Leiden, Netherlands
New developments in soft tissue and bone sarcoma research ( Prof Hans Gelderblom - Universiteit Leiden, Leiden, Netherlands )
21 Mar 2019
Results from the Health ABC study on accelerated sarcopenia in older cancer pati...
Dr Grant Williams - University of Alabama, Alabama, USA
Results from the Health ABC study on accelerated sarcopenia in older cancer patients ( Dr Grant Williams - University of Alabama, Alabama, USA )
23 Nov 2018
Safety analysis of entrectinib for NTRK fusion tumours
Dr George D. Demetri - Harvard Cancer Center, Boston, USA
Safety analysis of entrectinib for NTRK fusion tumours ( Dr George D. Demetri - Harvard Cancer Center, Boston, USA )
26 Oct 2018
Editor's Choice for June 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for June 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
4 Jul 2018
Adoptive cell therapy for solid tumours
Dr Sophie Papa - Guy's Hospital, London, UK
Adoptive cell therapy for solid tumours ( Dr Sophie Papa - Guy's Hospital, London, UK )
18 Oct 2017
CheckMate 214: nivolumab ipilimumab vs sunitinib for advanced or metastatic re...
Dr Bernard Escudier - Institut Gustave Roussy, Villejuif, France
CheckMate 214: nivolumab   ipilimumab vs sunitinib for advanced or metastatic renal cell carcinoma ( Dr Bernard Escudier - Institut Gustave Roussy, Villejuif, France )
10 Sep 2017